OSR Holdings, Inc. to Begin Trading on the
Nasdaq Stock Market LLC on Tuesday, February
18, 2025
Under the symbol "OSRH"
SEOUL,
South Korea, Feb. 14,
2025 /PRNewswire/ -- OSR Holdings, Inc. (formerly
Bellevue Life Sciences Acquisition Corp. (the "Company")) and OSR
Holdings Co., Ltd. ("OSR") announced today the completion of their
business combination (the "Business Combination").
The Company now operates as "OSR Holdings, Inc." following the
successful completion of the Business Combination. Beginning
on Tuesday, February 18, 2025, the
common stock and warrants of the Company are expected to begin
trading on the Nasdaq Stock Market LLC under the ticker symbols
"OSRH" and "OSRHW," respectively.
About OSR Holdings, Inc.
OSR Holdings, Inc. was a special purpose acquisition company
formed for the purpose of effecting a merger, capital stock
exchange, asset acquisition, stock purchase, reorganization or
similar business combination with one or more businesses.
Following the successful completion of the Business Combination,
the Company now owns approximately 67% of the outstanding stock of
OSR, and OSR stockholders holding an additional 22% of the
outstanding OSR shares have entered into agreements with the
Company providing for the acquisition by the Company of such shares
via put/call provisions commencing in 2026.
About OSR Holdings Co., Ltd.
OSR is a global healthcare company dedicated to advancing
healthcare outcomes and improving the quality of life for people
and their families. OSR aims to build and develop a robust
portfolio of innovative and potentially transformative therapies
and healthcare solutions. Its current operating businesses (through
three wholly-owned subsidiaries) include (i) developing
oral immunotherapies for the treatment of cancer,
(ii) developing design-augmented biologics for
age-related and other degenerative diseases and
(iii) neurovascular intervention medical device and systems
distribution in Korea. OSR's vision is to acquire and operate a
portfolio of innovative health-care related companies
globally.
Forward Looking Statements
This communication includes "forward-looking statements" within
the meaning of the "safe harbor" provisions of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements may be identified by the use of words such as
"estimate," "goal," "plan," "project," "forecast," "intend,"
"will," "expect," "anticipate," "believe," "seek," "target,"
"continue," "could," "may," "might," "possible," "potential,"
"predict" or other similar expressions that predict or indicate
future events or trends or that are not statements of historical
matters. These forward-looking statements include, but are not
limited to, statements regarding expectations and timing related to
the execution of OSR's mission to build and develop a robust
portfolio of innovative and potentially transformative therapies
and healthcare solutions. These forward-looking statements are
based on information available to us as of the date of this
communication and represent management's current views and
assumptions. Forward-looking statements are not guarantees of
future performance, events or results and involve known and unknown
risks, uncertainties and other factors, which may be beyond our
control.
These statements are based on various assumptions, whether or
not identified in this communication, and on the current
expectations of the Company and OSR's management and are not
predictions of actual performance. These forward-looking statements
are provided for illustrative purposes only and are not intended to
serve as and must not be relied on by any investor as, a guarantee,
an assurance, a prediction or a definitive statement of fact or
probability. Actual events and circumstances are difficult or
impossible to predict and will differ from assumptions. Many actual
events and circumstances are beyond the control of the Company and
OSR. These forward-looking statements are subject to known and
unknown risks, uncertainties and assumptions about the Company and
OSR that may cause our actual results, levels of activity,
performance or achievements to be materially different from any
future results, levels of activity, performance or achievements
expressed or implied by such forward-looking statements. Such risks
and uncertainties include risks related to OSR's ability to
execute on its strategy; regulatory uncertainties; the potential
need for financing to sustain the Company; market, financial,
political and legal conditions; the effects of competition; changes
in applicable laws or regulations; and the outcome of any
government and regulatory proceedings, investigations and
inquiries. If any of these risks materialize or our assumptions
prove incorrect, actual results could differ materially from the
results implied by the forward-looking statements. There may be
additional risks that we do not presently know or that we currently
believe are immaterial that could also cause actual results to
differ from those contained in the forward-looking statements. In
addition, forward-looking statements reflect our expectations,
plans or forecasts of future events and views as of the date of
this communication. We anticipate that subsequent events and
developments will cause our assessments to change. However, while
we may elect to update these forward-looking statements at some
point in the future, the Company and OSR specifically disclaim any
obligation to do so. These forward-looking statements should not be
relied upon as representing the Company's and OSR's assessments as
of any date subsequent to the date of this communication.
Accordingly, undue reliance should not be placed upon the
forward-looking statements. Additional information concerning
certain of these risk factors is contained in the Company's most
recent filings with the U.S. Securities and Exchange Commission,
including under the section entitled "Risk Factors" in the
prospectus filed on January 31, 2025
by the Company and other documents filed by the Company, or to be
filed by the Company, with the SEC.
Media Contact
Tae Min
Lee
OSR Holdings Co., Ltd.
Analyst
taemin.lee@osr-holdings.com
Investor Contact
Kuk Hyoun
Hwang
OSR Holdings, Inc.
Chairman & CEO
peter.hwang@osr-holdings.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/osr-holdings-inc-and-osr-holdings-co-ltd-announce-completion-of-business-combination-302377405.html
SOURCE OSR Holdings Inc.
